Patents Represented by Attorney Richard Warburg
  • Patent number: 6077675
    Abstract: A novel human metabotropic glutamate receptor (mGluR) protein is identified, sequenced, and cloned. The receptor may be used to screen for compounds that modulate the activity of the mGluR. The recombinant mGluR as well as compounds that modulate mGluR activity may be used in the diagnosis and treatment of neurological disorders and diseases.
    Type: Grant
    Filed: March 24, 1997
    Date of Patent: June 20, 2000
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Thomas M. Stormann, Rachel T. Simin, Lance G. Hammerland, Forrest H. Fuller
  • Patent number: 6074616
    Abstract: A fluorometer for sensing the fluorescence of a sample utilizes an optical energy source for exciting a sample to be tested and an optical energy detector for detecting the emitted energy from the excited sample. Drive electronics are used for positioning the sample with respect to the optical components allowing a plurality of sample regions to be tested. A processor is utilized to control the operation of the test in accordance with test instructions and for processing the emitted energy detected from the sample to determine test results. A ROM chip socket accepts a plurality of ROM chips, wherein each ROM chip stores test data sets for one or more test types to be performed. ROM chips can be swapped to allow the fluorometer to be configured and reconfigured to perform a plurality of different tests. A communications interface facilitates the sharing of test information between the fluorometer and external entities.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: June 13, 2000
    Assignee: Biosite Diagnostics, Inc.
    Inventors: Kenneth F. Buechler, Joseph M Anderberg, Paul H. McPherson
  • Patent number: 5489508
    Abstract: Method and compositions are provided for the determination of telomere length and telomerase activity, as well as the ability to inhibit telomerase activity in the treatment of proliferative diseases. Particularly, primers are elongated under conditions which minimize interference from other genomic sequences, so as to obtain accurate determinations of telomeric length or telomerase activity. In addition, compositions are provided for intracellular inhibition of telomerase activity.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: February 6, 1996
    Assignee: University of Texas System Board of Regents
    Inventors: Michael D. West, Jerry Shay, Woodring Wright